Hiperglucemia como factor pronóstico de complicaciones intrahospitalarias en el infarto agudo de miocardio con supradesnivel del segmento ST

Geovedy Martínez García

Authors

Geovedy Martínez García Hospital Militar Central Dr. Carlos Juan Finlay. Marianao, La Habana, Cuba.

Abstract

Introduction: Mortality and complications remains high in acute myocardial infarction (AMI) patients despite newer reperfusion techniques were being introduced. Hyperglycemia has been described in several studies as a risk factor and worse prognosis.

Objectives: To demonstrate the importance of hyperglycemia as a risk factor for in-hospital complications in ST-segment elevation AMI.

Method: Analytical, longitudinal and prospective cohort study, from 2013 to 2017, which included 307 consecutive patients who were admitted to the Intensive Coronary Care Unit of the Hospital Militar Central Dr. Carlos J. Finlay, with an ST-segment elevation AMI diagnosis.

Results: Mean age was 63.8±11.8 years and the male sex prevailed (61.8%). The main risk factors were high blood pressure and smoking. Of all patients, 119 (38.8%) suffered in-hospital complications. Age ≥ 60 years, Killip-Kimball functional class ≥ II, non-performance of percutaneous coronary intervention and hospital stay were independent prognostic factors of adverse events during admission. Fasting hyperglycemia was shown as an independent predictor of complications from binary logistic regression (p=0.0035, β=0.2971).

Conclusions: Hyperglycemia, measured through fasting blood glucose, is an independent predictor of in-hospital complications in patients with ST-segment elevation AMI.

Downloads

Download data is not yet available.

References

1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics – 2016 Update: A report from the American Heart Association. Circulation. 2016;133(4):e38-360.

2. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Documento de consenso de expertos. Tercera definición universal del infarto de miocardio. Rev Esp Cardiol. 2013;66(2):132.e1-15.

3. Li S, Fonarow GC, Mukamal KJ, Liang L, Schulte PJ, Smith EE, et al. Sex and race/ethnicity-related disparities in care and outcomes after hospitalization for coronary artery disease among older adults. Circ Cardiovasc Qual Outcomes. 2016;9(2 Supl 1):S36-44.

4. Ministerio de Salud Pública. Anuario Estadístico de Salud 2017. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2018.

5. Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37(42):3232-45.

6. Bajaj A, Sethi A, Rathor P, Suppogu N, Sethi A. Acute complications of myocardial infarction in the current era: diagnosis and management. J Investig Med. 2015;63(7):844-55.

7. Schiele F, Gale CP, Bonnefoy E, Capuano F, Claeys MJ, Danchin N, et al. Quality indicators for acute myocardial infarction: A position paper of the Acute Cardiovascular Care Association. Eur Heart J Acute Cardiovasc Care. 2017;6(1):34-59.

8. Bebb O, Hall M, Fox KAA, Dondo TB, Timmis A, Bueno H, et al. Performance of hospitals according to the ESC ACCA quality indicators and 30-day mortality for acute myocardial infarction: national cohort study using the United Kingdom Myocardial Ischaemia National Audit Project (MINAP) register. Eur Heart J. 2017;38(13):974-82.

9. Ibáñez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. Guía ESC 2017 sobre el tratamiento del infarto agudo de miocardio en pacientes con elevación del segmento ST. Rev Esp Cardiol. 2017;70(12):1082.e1-e61.

10. Jneid H, Addison D, Bhatt DL, Fonarow GC, Gokak S, Grady KL, et al. 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction. A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol. 2017;70(16):2048-90.

11. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284(7):835-42.

12. Senthinathan A, Kelly V, Dzingina M, Jones D, Baker M, Longson D, et al. Hyperglycaemia in acute coronary syndromes: summary of NICE guidance. BMJ [Internet]. 2011 [citado 22 Sep 2018];343:d6646. Disponible en: https://doi.org/10.1136/bmj.d6646

13. Mi SH, Su G, Yang HX, Zhou Y, Tian L, Zhang T, et al. Comparison of in-hospital glycemic variability and admission blood glucose in predicting short-term outcomes in non-diabetes patients with ST elevation myocardial infarction underwent percutaneous coronary intervention. Diabetol Metab Syndr [Internet]. 2017 [citado 22 Sep 2018];9:20. Disponible en: https://dmsjournal.biomedcentral.com/track/pdf/10.1186/s13098-017-0217-1

14. American Diabetes Association. Diagnosis and classification of Diabetes Mellitus. Diabetes Care. 2011;34(Supl 1):62-9.

15. Zhao S, Murugiah K, Li N, Li X, Xu ZH, Li J, et al. Admission glucose and in‑hospital mortality after acute myocardial infarction in patients with or without diabetes: A cross-sectional study. Chin Med J. 2017;130(7):767-75.

16. Galindo-García G, Galván-Plata ME, Nellen-Hummel H, Almeida-Gutiérrez E. Asociación entre hiperglucemia de estrés y complicaciones intrahospitalarias. Rev Med Inst Mex Seguro Soc. 2015;53(1):6-12.

17. Santos M, Barreiro A, García RC, Barreiro AE. Factores de riesgo de mortalidad hospitalaria post infarto agudo de miocardio. Rev Cuban Cardiol [Internet]. 2017 [citado 25 Sep 2018];23(3):371-86. Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/710/pdf_91

18. Karetnikova V, Gruzdeva O, Uchasova E, Osokina A, Barbarash O. Glucose levels as a prognostic marker in patients with ST-segment elevation myocardial infarction: a case-control study. BMC Endocr Disord [Internet]. 2016 [citado 25 Sep 2018];16(1):31. Disponible en: https://bmcendocrdisord.biomedcentral.com/track/pdf/10.1186/s12902-016-0108-8

19. Kalińczuk Ł, Zieliński K, Pręgowski J, Przyłuski J, Karcz M, Bekta P, et al. Higher admission glycaemia independently of diagnosed or unrecognised diabetes mellitus is a risk factor for failed myocardial tissue reperfusion and higher mortality after primary angioplasty. Kardiol Pol. 2018;76(3):594-601.

20. Gomez-Arbelaez D, Sánchez-Vallejo G, Perez M, Gerardo RG, Arguello JF, Peñaherrera E, et al. Hiperglucemia se asocia a mayor número de desenlaces adversos en individuos latinoamericanos con infarto agudo de miocardio. Clin Investig Arterioscler. 2016;28(1):9-18.

21. Issa M, Alqahtani F, Berzingi C, Al‑Hajji M, Busu Y, Alkhouli M. Impact of acute diabetes decompensation on outcomes of diabetic patients admitted with ST-elevation myocardial infarction. Diabetol Metab Syndr [Internet]. 2018 [citado 27 Sep 2018];10:57. Disponible en: https://doi.org/10.1186/s13098-018-0357-y

22. Lee TF, Burt MG, Heilbronn LK, Mangoni AA, Wong VW, McLean M, et al. Relative hyperglycemia is associated with complications following an acute myocardial infarction: a post-hoc analysis of HI-5 data. Cardiovasc Diabetol [Internet]. 2017 [citado 27 Sep 2018];16(1):157. Disponible en: https://doi.org/10.1186/s12933-017-0642-3

23. Canto J, Rogers WJ, Goldberg RJ, Peterson ED, Wenger NK, Vaccarino V, et al. Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA. 2012;307(8):813-22.

24. Egi M, Bellomo R, Stachowski E, French CJ, Hart G, Stow P. Circadian rhythm of blood glucose values in critically ill patients. Crit Care Med. 2007;35(2):416-21.